Enhancement strategy for effective vascular regeneration following myocardial infarction through a dual stem cell approach
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Since an impaired coronary blood supply following myocardial infarction (MI) negatively affects heart function, therapeutic neovascularization is considered one of the major therapeutic strategies for cell-based cardiac repair. Here, to more effectively achieve therapeutic neovascularization in ischemic hearts, we developed a dual stem cell approach for effective vascular regeneration by utilizing two distinct types of stem cells, CD31+-endothelial cells derived from human induced pluripotent stem cells (hiPSC-ECs) and engineered human mesenchymal stem cells that continuously secrete stromal derived factor-1α (SDF-eMSCs), to simultaneously promote natal vasculogenesis and angiogenesis, two core mechanisms of neovascularization. To induce more comprehensive vascular regeneration, we intramyocardially injected hiPSC-ECs to produce de novo vessels, possibly via vasculogenesis, and a 3D cardiac patch encapsulating SDF-eMSCs (SDF-eMSC-PA) to enhance angiogenesis through prolonged secretion of paracrine factors, including SDF-1α, was implanted into the epicardium of ischemic hearts. We verified that hiPSC-ECs directly contribute to de novo vessel formation in ischemic hearts, resulting in enhanced cardiac function. In addition, the concomitant implantation of SDF1α-eMSC-PAs substantially improved the survival, retention, and vasculogenic potential of hiPSC-ECs, ultimately achieving more comprehensive neovascularization in the MI hearts. Of note, the newly formed vessels through the dual stem cell approach were significantly larger and more functional than those formed by hiPSC-ECs alone. In conclusion, these results provide compelling evidence that our strategy for effective vascular regeneration can be an effective means to treat ischemic heart disease.
Abstract
Since an impaired coronary blood supply following myocardial infarction (MI) negatively affects heart function, therapeutic neovascularization is considered one of the major therapeutic strategies for cell-based cardiac repair. Here, to more effectively achieve therapeutic neovascularization in ischemic hearts, we developed a dual stem cell approach for effective vascular regeneration by utilizing two distinct types of stem cells, CD31+-endothelial cells derived from human induced pluripotent stem cells (hiPSC-ECs) and engineered human mesenchymal stem cells that continuously secrete stromal derived factor-1α (SDF-eMSCs), to simultaneously promote natal vasculogenesis and angiogenesis, two core mechanisms of neovascularization. To induce more comprehensive vascular regeneration, we intramyocardially injected hiPSC-ECs to produce de novo vessels, possibly via vasculogenesis, and a 3D cardiac patch encapsulating SDF-eMSCs (SDF-eMSC-PA) to enhance angiogenesis through prolonged secretion of paracrine factors, including SDF-1α, was implanted into the epicardium of ischemic hearts. We verified that hiPSC-ECs directly contribute to de novo vessel formation in ischemic hearts, resulting in enhanced cardiac function. In addition, the concomitant implantation of SDF1α-eMSC-PAs substantially improved the survival, retention, and vasculogenic potential of hiPSC-ECs, ultimately achieving more comprehensive neovascularization in the MI hearts. Of note, the newly formed vessels through the dual stem cell approach were significantly larger and more functional than those formed by hiPSC-ECs alone. In conclusion, these results provide compelling evidence that our strategy for effective vascular regeneration can be an effective means to treat ischemic heart disease.
참고문헌 (42)
- Nowbar, A. N., "Mortality from ischemic heart disease", Circ. Cardiovasc. Qual. Outcomes, 12, pp.e005375~ (2019)
- Saleh, M., "Understanding myocardial infarction", F1000Res, 7, pp.F1000~ (2018)[DOI]
- Clayton, Z. E., "Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis", Int. J. Cardiol, 197, pp.116~122 (2015)
- Gupta, R., "Human studies of angiogenic gene therapy", Circ. Res, 105, pp.724~736 (2009)
- Phelps, E. A., "Update on therapeutic vascularization strategies", Regen. Med, 4, pp.65~80 (2009)
- Tang, J., "Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats", Eur. J. Cardiothorac. Surg, 36, pp.644~650 (2009)
- Kubis, N., "Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors", Interv. Neuroradiol, 9, pp.227~237 (2003)
- Ribatti, D., "Postnatal vasculogenesis", Mech. Dev, 100, pp.157~163 (2001)
- Balaji, S., "The role of endothelial progenitor cells in postnatal vasculogenesis : implications for therapeutic neovascularization and wound healing", Adv. Wound Care(N. Rochelle), 2, pp.283~295 (2013)
- Schuh, A., "Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model", Basic. Res. Cardiol, 103, pp.69~77 (2008)
- Tang, J., "Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion", Eur. J. Cardiothorac. Surg, 30, pp.353~361 (2006)
- Ziegler, M., "Platelet-targeted delivery of peripheral blood mononuclear cells to the ischemic heart restores cardiac function after ischemia-reperfusion injury", Theranostics, 7, pp.3192~3206 (2017)
- Nesselmann, C., "Stem cell-mediated neovascularization in heart repair", Ther. Adv. Cardiovasc. Dis, 4, pp.27~42 (2010)
- Chao, T. -H., "Pluripotent stem cell therapy in ischemic cardiovascular disease", Acta Cardiol. Sin, 30, pp.365~374 (2014)
- Templin, C., "Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography", computed tomography of sodium iodide symporter transgene expression, 2012, pp.126, 430~439
- Park, B. W., "In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair", Sci. Adv, 6, pp.eaay6994~ (2020)
- Park, S. -J., "Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction", Nat. Commun, 10, pp.3123~3123 (2019)
- Ban, K., "Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair", ACS Nano, 8, pp.10815~10825 (2014)
- Ban, K., "Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA", Circulation, 128, pp.1897~1909 (2013)
- Lee, S., "In vivo combinatory gene therapy synergistically promotes cardiac function and vascular regeneration following myocardial infarction", J. Tissue Eng, 11, pp.2041731420953413~2041731420953413 (2020)
- 이성훈, "In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarction", Experimental and Molecular Medicine, 51, pp.1~14 (2019), 생화학분자생물학회[DOI]
- Lian, X., "Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling", Stem Cell Rep, 3, pp.804~816 (2014)
- Jeon, S. H., "Engineered mesenchymal stem cells expressing stromal cellderived factor-1 improve erectile dysfunction in streptozotocin-induced diabetic rats", Int. J. Mol. Sci, 19, pp.3730~ (2018)
- Kim, H. -K., "A subset of paracrine factors as efficient biomarkers for predicting vascular regenerative efficacy of mesenchymal stromal", stem cells, 2019, pp.37, 77~88
- Nguyen, M., "A role for sialyl Lewis-X", A glycoconjugates in capillary morphogenesis, 1993, pp.365, 267~269
- Aoki, M., "Effects of vascular endothelial growth factor and E-selectin on angiogenesis in the murine metastatic RCT sarcoma", Tumour Biol, 22, pp.239~246 (2001)
- Bischoff, J., "E-selectin is upregulated in proliferating endothelial cells in vitro", Microcirculation, 4, pp.279~287 (1997)
- Kevil, C. G., "Intercellular adhesion molecule-1(ICAM-1)regulates endothelial cell motility through a nitric oxide-dependent pathway", J. Biol. Chem, 279, pp.19230~19238 (2004)
- Gho, Y. S., "Angiogenic activity of human soluble intercellular adhesion molecule-1", Cancer Res, 59, pp.5128~5132 (1999)
- Jujo, K., "Endothelial progenitor cells in neovascularization of infarcted myocardium", J. Mol. Cell. Cardiol, 45, pp.530~544 (2008)
- Tang, X. L., "Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction", Circulation, 121, pp.293~305 (2010)
- Thi Van Anh Bui, "Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair", Korean Circulation Journal, 51(2), pp.97~113 (2021), 대한심장학회[DOI]
- Sim, W. -S., "In situ preconditioning of human mesenchymal stem cells elicits comprehensive cardiac repair following myocardial infarction", Int. J. Mol. Sci, 22, pp.1449~ (2021)
- Gu, M., "Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation", Circ. Res, 111, pp.882~893 (2012)
- Lee, A. S., "Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells", J. Biol. Chem, 286, pp.32697~32704 (2011)
- Clayton, Z. E., "Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model", Biosci. Rep, 38, pp.BSR2018056~ (2018)
- Rufaihah, A. J., "Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease", Arterioscler. Thromb. Vasc. Biol, 31, pp.e72~e79 (2011)
- Clayton, Z. E., "A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease", Int. J. Cardiol, 234, pp.81~89 (2017)
- Penn, M. S., "SDF-1 in myocardial repair", Gene. Ther, 19, pp.583~587 (2012)
- Saxena, A., "Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction", Circulation, 117, pp.2224~2231 (2008)
- Atluri, P., "Normalization of postinfarct biomechanics using a novel tissueengineered angiogenic construct", Circulation, 128, pp.S95~S104 (2013)
- Terrovitis, J. V., "Assessment and optimization of cell engraftment after transplantation into the heart", Circ. Res, 106, pp.479~494 (2010)